• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛内皮细胞纤溶酶原激活物抑制剂。纯化与热激活。

Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.

作者信息

Katagiri K, Okada K, Hattori H, Yano M

机构信息

Central Research Laboratories, Banyu Pharmaceutical Co. Ltd, Tokyo, Japan.

出版信息

Eur J Biochem. 1988 Sep 1;176(1):81-7. doi: 10.1111/j.1432-1033.1988.tb14253.x.

DOI:10.1111/j.1432-1033.1988.tb14253.x
PMID:3262060
Abstract

A plasminogen activator inhibitor (PAI) was purified from bovine endothelial cell conditioned medium by a simple procedure in the absence of protein denaturant. The yield was 2.2 mg from 1.61 conditioned medium in a typical experiment. The purified inhibitor showed a single band on sodium dodecyl sulfate/polyacrylamide gel electrophoresis and reverse fibrin autography with an apparent molecular mass of 45 kDa. The amino-terminal 40-amino-acid sequence was determined and found to be 70% similar to the reported corresponding sequence of human PAI-1. The amino acid composition also revealed a close relationship between bovine PAI and human PAI-1. The purified PAI was substantially inactive (570 U/mg) but it could be activated by treatment with protein denaturants such as 1% SDS (1.8 X 10(5) U/mg) and 4 M guanidine-HCl (1.5 X 10(5) U/mg). A more effective activation of this latent PAI was achieved by heat treatment at 100 degrees C for 2.5 min, generating the specific activity of 1.0 X 10(6) U/mg. The heat-activated PAI lost its activity during incubation at 56 degrees C for 30 min, but repeated heat at 100 degrees C for 2.5 min could regenerate about 70% of the initial activity. Treatment at 37 degrees C, 56 degrees C and 80 degrees C, however, failed to activate the latent PAI at all. These findings suggest that the buried reactive site of the latent PAI is exposed as a result of a heat-induced, specific conformational change, but tends to be masked again during renaturation under mild conditions, i.e. the PAI protein takes on preferentially a latent form.

摘要

采用一种简单方法,在无蛋白质变性剂的情况下,从牛内皮细胞条件培养基中纯化出一种纤溶酶原激活物抑制剂(PAI)。在典型实验中,从1.6升条件培养基中获得了2.2毫克的产量。纯化后的抑制剂在十二烷基硫酸钠/聚丙烯酰胺凝胶电泳和反向纤维蛋白自显影中显示为单一条带,表观分子量为45 kDa。测定了氨基末端的40个氨基酸序列,发现与报道的人PAI-1相应序列有70%的相似性。氨基酸组成也显示牛PAI与人PAI-1之间存在密切关系。纯化的PAI基本上无活性(570 U/mg),但用1% SDS(1.8×10⁵ U/mg)和4 M盐酸胍(1.5×10⁵ U/mg)等蛋白质变性剂处理可使其激活。通过在100℃热处理2.5分钟可更有效地激活这种潜在的PAI,产生的比活性为1.0×10⁶ U/mg。热激活的PAI在56℃温育30分钟期间失去活性,但在100℃重复加热2.5分钟可使约70%的初始活性再生。然而,在37℃、56℃和80℃处理根本无法激活潜在的PAI。这些发现表明,潜在PAI被掩埋的反应位点由于热诱导的特定构象变化而暴露,但在温和条件下复性过程中又倾向于再次被掩盖,即PAI蛋白优先呈现潜在形式。

相似文献

1
Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.牛内皮细胞纤溶酶原激活物抑制剂。纯化与热激活。
Eur J Biochem. 1988 Sep 1;176(1):81-7. doi: 10.1111/j.1432-1033.1988.tb14253.x.
2
Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.纤溶酶原激活物抑制剂1与尿激酶和组织纤溶酶原激活物之间相互作用的动力学分析
Arch Biochem Biophys. 1988 Apr;262(1):199-210. doi: 10.1016/0003-9861(88)90182-8.
3
Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.HTC大鼠肝癌细胞纤溶酶原激活物抑制剂-1的免疫亲和纯化
Thromb Haemost. 1987 Dec 18;58(4):1017-23.
4
Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.
Biochemistry. 1988 Apr 19;27(8):2911-8. doi: 10.1021/bi00408a037.
5
Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.内皮细胞产生一种纤溶酶原激活物的潜在抑制剂,该抑制剂可被变性剂激活。
J Biol Chem. 1985 Sep 25;260(21):11581-7.
6
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
J Biol Chem. 1988 Oct 25;263(30):15454-61.
7
Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.
Blood. 1987 Oct;70(4):1090-8.
8
Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
Eur J Biochem. 1988 Aug 15;175(3):531-40. doi: 10.1111/j.1432-1033.1988.tb14225.x.
9
Plasminogen activator inhibitor type 1 production by rat type II pneumocytes in culture.培养的大鼠II型肺细胞产生1型纤溶酶原激活物抑制剂
Am J Respir Cell Mol Biol. 1992 Feb;6(2):133-9. doi: 10.1165/ajrcmb/6.2.133.
10
Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.从人黑色素瘤细胞系的条件培养基中纯化一种与内皮型纤溶酶原激活物抑制剂具有免疫相关性的活性纤溶酶原激活物抑制剂。
J Biol Chem. 1986 Nov 5;261(31):14474-81.

引用本文的文献

1
Functional stability of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1的功能稳定性
ScientificWorldJournal. 2014;2014:858293. doi: 10.1155/2014/858293. Epub 2014 Oct 15.
2
What is the role of non-native intermediates of beta-lactoglobulin in protein folding?β-乳球蛋白的非天然中间体在蛋白质折叠中起什么作用?
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14273-7. doi: 10.1073/pnas.97.26.14273.
3
cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1).牛1型纤溶酶原激活物抑制剂(PAI - 1)的互补DNA
Nucleic Acids Res. 1989 Nov 11;17(21):8872. doi: 10.1093/nar/17.21.8872.